Clinical Trial

Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

Name: Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease — clinical trial record (NCT06925594)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy of human TH-SC01 cell injection for the treatment of perianal fistulas in Crohn's Disease over 24 weeks.

Trial Details

NCT Number	NCT06925594
Lead Sponsor	Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Conditions	Crohn's Disease
Enrollment	228 participants
Start Date	2025-03-20
Primary Completion	2026-12-28 (estimated)
Study Completion	2028-06-28 (estimated)
Updated on ClinicalTrials.gov	2025-04-13